From FDA labels and ClinicalTrials.gov
What GLP-1s are studied for
ClinicalTrials.gov holds 2,099 trials of these medicines, 481 with posted results. Of the 19 conditions below, FDA has approved at least one GLP-1 for 5. A registered trial shows a question being asked, not that the answer is yes.
Read from the registry every day. The newest update is Nov 5, 2026.
By condition
Every condition with its own page
Each page has the label's approved use, the trials by medicine, what they reported and what is recruiting. One trial can count under several conditions.
| Condition | FDA approved | Trials | Posted results | Recruiting |
|---|---|---|---|---|
| Heart disease | Wegovy, Trulicity, Victoza, Mounjaro, Ozempic, Rybelsus/Ozempic tablets | 96 | 13 | 16 |
| Type 1 diabetes | None | 85 | 21 | 15 |
| Fatty liver (MASH, NAFLD) | Wegovy | 72 | 12 | 9 |
| Kidney disease | Ozempic | 67 | 14 | 15 |
| Teens and children | Wegovy, Trulicity, Saxenda, Victoza, Mounjaro | 65 | 19 | 20 |
| After bariatric surgery | None | 49 | 4 | 11 |
| Prediabetes | None | 36 | 14 | 6 |
| Heart failure | None | 36 | 5 | 6 |
| PCOS | None | 33 | 6 | 6 |
| Cancer | None | 29 | 0 | 13 |
| Alcohol use | None | 23 | 2 | 8 |
| Knee osteoarthritis | None | 18 | 2 | 0 |
| Psoriasis | None | 16 | 0 | 4 |
| Alzheimer's and dementia | None | 15 | 3 | 3 |
| Schizophrenia and bipolar | None | 14 | 2 | 2 |
| Sleep apnea | Zepbound | 13 | 3 | 2 |
| Smoking | None | 13 | 4 | 5 |
| HIV | None | 12 | 3 | 4 |
| Parkinson's | None | 9 | 1 | 0 |
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.